Display Settings:

Format

Send to:

Choose Destination

    Arthritis Res. 2002;4(2):77-9. Epub 2001 Oct 26.

    Staphylococcus aureus and Wegener's granulomatosis.

    Popa ER, Stegeman CA, Kallenberg CG, Tervaert JW.

    Department of Clinical Immunology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

    Wegener's granulomatosis (WG) is a form of systemic vasculitis. It is characterized by granulomatous inflammation in the upper and lower airways, vasculitis and necrotizing glomerulonephritis, and is strongly associated with antineutrophil cytoplasmic antibodies against proteinase 3. Since the etiology of the disease is not clear, treatment, consisting of corticosteroids and immunosuppressives, is nonspecific and associated with severe side effects. Pinpointing the trigger(s) of the disease would highly improve treatment. Clinical evidence shows that an infectious agent, the bacterium Staphylococcus aureus, is a risk factor for disease relapse, suggesting its involvement in the pathogenesis of WG. Here we review both clinical and experimental data that either indicate or support a role for S. aureus in WG.

    PMID: 11879541 [PubMed - indexed for MEDLINE]

    PMCID: PMC128917

    Supplemental Content

    Click here to read Click here to read